Biggest Holdings Increases
The largest buys based on how much the insider increased their holdings.
None
Biggest Holdings Decreases
The largest sells based on how much the insider decreased their holdings.
Chief Financial Officer at X4 Pharmaceuticals, Inc ($XFOR) sold 230,645 shares at $0.55/share ($127K total) which decreased their vested holdings by 100.0%. Their median sale size is $26,876.90 and this is their 2nd largest sale out of 20 all time – (SEC Source). 4 other insiders also sold the stock. Is part of 10b5-1 plan
Director at NUSCALE POWER Corp ($SMR) sold 68,558 shares at $13.02/share ($893K total) which decreased their vested holdings by 68.1%. Their median sale size is $404K and this is their 5th largest sale out of 11 all time – (SEC Source)
Director at MoonLake Immunotherapeutics ($MLTX) sold 171,000 shares at $53.72/share ($9.19M total) which decreased their vested holdings by 49.9%. Their median sale size is $9.19M and this is their 1st largest sale out of 1 all time – (SEC Source)
Largest Buys
The largest insider buys based on dollar value.
President and CEO at ANGIODYNAMICS INC ($ANGO) purchased 20,000 shares at $6.03/share ($121K total) which increased their vested holdings by 3.0%. Their median purchase size is $213K and this is their 6th largest purchase out of 7 all time – (SEC Source). 1 other insiders also purchased the stock
Largest Sells
The largest insider sells based on dollar value.
President and CEO at Trade Desk, Inc. ($TTD) sold 400,000 shares at $112.63/share ($45.05M total) which decreased their vested holdings by 27.4%. Their median sale size is $6.22M and this is their 10th largest sale out of 58 all time – (SEC Source). Is part of 10b5-1 plan
The 10% Owner at ACM Research, Inc. ($ACMR) sold 1,065,400 shares at $22.08/share ($23.52M total) which decreased their vested holdings by 15.8%. Their median sale size is $12.11M and this is their 1st largest sale out of 2 all time – (SEC Source). 2 other insiders also sold the stock. Is part of 10b5-1 plan
Director at ACM Research, Inc. ($ACMR) sold 1,065,400 shares at $22.07/share ($23.52M total) which decreased their vested holdings by 31.3%. Their median sale size is $12.11M and this is their 1st largest sale out of 2 all time – (SEC Source). 2 other insiders also sold the stock. Is part of 10b5-1 plan
The 10% Owner at FrontView REIT, Inc. ($FVR) sold 1,008,740 shares at $18.32/share ($18.48M total) which decreased their vested holdings by 25.6%. Their median sale size is $2.09M and this is their 1st largest sale out of 3 all time – (SEC Source)
Chairman, President & CEO at BOSTON SCIENTIFIC CORP ($BSX) sold 162,777 shares at $84.63/share ($13.78M total) which decreased their vested holdings by 7.3%. Their median sale size is $5.22M and this is their 1st largest sale out of 24 all time – (SEC Source). 1 other insiders also sold the stock. Is part of 10b5-1 plan
Senior Vice President, CFO at Apple Inc. ($AAPL) sold 59,305 shares at $226.52/share ($13.43M total) which decreased their vested holdings by 35.5%. Their median sale size is $1.39M and this is their 8th largest sale out of 39 all time – (SEC Source). Is part of 10b5-1 plan
EVP & Group Pres, Cardiology at BOSTON SCIENTIFIC CORP ($BSX) sold 132,527 shares at $85.00/share ($11.26M total) which decreased their vested holdings by 44.5%. Their median sale size is $2.01M and this is their 1st largest sale out of 16 all time – (SEC Source). 1 other insiders also sold the stock. Is part of 10b5-1 plan
Disclaimer: The content provided by InsiderEdge™ is for informational purposes only and does not constitute investment advice, an offer to sell, or a solicitation of an offer to buy any securities. The historical performance noted in this post is not is not indicative of future results. Investing involves risk, including the potential loss of principal. Use the platform at your own risk and consult a financial advisor before making any investment decisions. In partnership with Yellowbrick Investing Inc.
